Circulating Tumor DNA and Follow-up of BRCA1 Mutation Carriers (CirCa 01)

Clinical trial NCT02608346 · COMPLETED

Trial details

NCT number: NCT02608346
Sponsor: Institut Curie
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Women With BRCA1 Germline Deleterious Mutation

Start date: 2014-11-01
Primary completion: 2021-12-29
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.